Early Tumor–Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer

Chemotherapy is ubiquitous in first-line treatment of advanced gastric cancer, yet responses are heterogeneous, and little is known about mediators of chemotherapy response. To move forward, an understanding of the effects of standard chemotherapy on the tumor–immune microenvironment (TME) is needed...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ryul, An, Minae, Lee, Hyuk, Mehta, Arnav, Heo, You Jeong, Kim, Kyoung-Mee, Lee, Song-Yi, Moon, Jeonghyeon, Kim, Seung Tae, Min, Byung-Hoon, Kim, Tae Jun, Rha, Sun Young, Kang, Won Ki, Park, Woong-Yang, Klempner, Samuel J., Lee, Jeeyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387589/
https://www.ncbi.nlm.nih.gov/pubmed/34933901
http://dx.doi.org/10.1158/2159-8290.CD-21-0888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387589/
https://www.ncbi.nlm.nih.gov/pubmed/34933901
http://dx.doi.org/10.1158/2159-8290.CD-21-0888

Ejemplares similares